• DiscoveryProbe Immunology/Inflammation Compound Library

  2026-09-09

  Pair a curated 295-compound collection with multiplex PBMC flow cytometry to distinguish immune activation, proliferation, and toxicity in one experiment. This workflow turns broad immunomodulator screening compounds into actionable inflammation target validation and immune pathway profiling data.

• Guanabenz Acetate: GPCR Assay Workflows

  2026-09-08

  Build reproducible α2-adrenergic receptor assays with a DMSO-compatible agonist, subtype-aware concentration design, and practical controls for solubility and vehicle effects. The workflow also shows how receptor perturbation can be paired cautiously with stress-granule and innate-immunity readouts without overstating antiviral evidence.

• HOBt for Precise Amide Bond Formation

  2026-09-08

  HOBt combines mild activation with stereochemical control for peptide synthesis, medicinal-chemistry amide coupling, and analogue construction. This practical guide translates the EDC/HOBt workflow reported for indazole glucagon receptor antagonists into reproducible setup, optimization, and troubleshooting decisions.

• HyperScript III RT SuperMix for CRC qPCR

  2026-09-07

  HyperScript III RT SuperMix supports two-step qRT-PCR workflows for challenging RNA, including high-GC content RNA and low-copy transcripts. Its integrated gDNA wiper addresses genomic DNA contamination removal before cDNA synthesis, supporting more reliable gene expression analysis by qPCR in colorectal cancer biomarker studies.

• PEGylated Iron Oxide Nanoparticles in the Liver

  2026-09-07

  The reference study systematically separates the effects of iron oxide nanoparticle size and PEG chain length on hepatic distribution and uptake by primary liver cell populations. Its combination of 99mTc-SPECT/CT imaging with cell-specific assays shows that hepatocytes and stellate cells can contribute substantially to nanoparticle uptake, while 2K PEG may provide a useful balance between circulation and reduced liver sequestration.

• BOP Reagent for Peptide Coupling Workflows

  2026-09-05

  BOP reagent supports controlled carboxyl group activation for phenyl ester preparation, blocked amino acid derivatives, and amide bond formation. This practical guide connects bench-scale coupling design with assay planning inspired by a carrier-free triterpene prodrug study, while clearly separating established chemistry from translational hypotheses.

• Guanabenz Acetate in α2-Receptor Research

  2026-09-04

  Guanabenz Acetate provides a subtype-aware pharmacological entry point for studying α2-adrenergic signaling, from receptor assays to cellular stress responses. This workflow-focused guide shows how to connect GPCR perturbation with GADD34, stress-granule, and IRF3 readouts without overstating evidence from viral immunity research.

• HOBt for High-Fidelity Amide Bond Formation

  2026-09-04

  HOBt supports efficient, mild amide bond formation when stereochemical fidelity and substrate compatibility matter. This applied guide connects coupling optimization with peptide synthesis, medicinal chemistry workflows, and the indazole-based glucagon receptor antagonist study.

• Laminin (925-933) for ECM Migration Assays

  2026-09-03

  Laminin (925-933) is a defined Laminin B1 chain peptide for separating receptor-driven adhesion and chemotaxis from the complexity of full-length ECM. Its documented activity in HT-1080, CHO, and B16F10 models also makes it a practical control or perturbation tool for basement membrane protein research and engineered organoid matrices.

• Guanabenz Acetate: Assay Design for α2 Signaling

  2026-09-03

  Guanabenz Acetate can serve as a precise α2-adrenergic receptor agonist for separating receptor-proximal signaling from downstream stress and innate-immune phenotypes. This article translates recent GADD34–stress-granule findings into a rigorous, hypothesis-driven assay framework while clearly defining what remains unproven.

• PDGF-BB in Pulmonary Vascular Remodeling Assays

  2026-09-02

  Use PDGF-BB, murine recombinant PDGF-BB as a defined mitogenic input for dose-response, receptor-signaling, and pulmonary vascular remodeling experiments. This workflow extends conventional proliferation testing into hypoxia, lactate metabolism, ALDOB lactylation, and mitochondrial phenotyping while preserving clear controls and troubleshooting checkpoints.

• GLI2–PRDX1 Ferroptosis Resistance in Bladder Cancer

  2026-09-02

  The reference study identifies a GLI2–PRDX1 transcriptional axis that suppresses ferroptosis and supports malignant progression in bladder cancer. Its combination of public-data analysis, RNA sequencing, chromatin immunoprecipitation, genetic perturbation, and rescue experiments suggests that GLI2 inhibition may improve responses to PRDX1-directed treatments and cisplatin.

• HOBt in Amide Bond Formation: A Mechanistic Guide

  2026-09-01

  Explore how HOBt (1-Hydroxybenzotriazole) controls activated ester chemistry, supports stereochemically reliable peptide synthesis, and enabled a key amide-forming step in glucagon receptor antagonist discovery. This guide connects reagent selection, hydrate-aware handling, and medicinal chemistry decision-making.

• Protease Inhibitor Cocktail: EDTA-Free Workflow

  2026-09-01

  Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) helps limit proteolytic damage during cell lysis, protein extraction, and protease-sensitive downstream assays. It is suited to workflows requiring divalent cations, but it should not be treated as a universal inhibitor system or as a replacement for rapid, cold sample handling and separately validated phosphatase control.

• Cy3 NHS ester (non-sulfonated): Practical Guide

  2026-08-31

  Cy3 NHS ester (non-sulfonated) provides an orange fluorescent, amine-reactive labeling option for proteins, peptides, oligonucleotides, and DNA. It is suitable when a DMSO, DMF, or other compatible organic co-solvent is acceptable, but it is a poor choice for strictly aqueous workflows or long-term storage of prepared solutions.

7869 records 1/525 page Next 12345 下5页 Last page